CRP and cancer: From all the factors identified in our COVID-19-related death analysis, only haematological cancer type, a longer-established cancer diagnosis (2–5 years and >5 years), dyspnoea at the time of diagnosis and high levels of CRP were indicative of an early COVID-19-related death (within 7 days of diagnosis) in cancer patients.